Ganzer U, Ryzmann G, Vosteen K H
Arch Otorhinolaryngol. 1977 Feb 15;214(4):291-302. doi: 10.1007/BF00457470.
Formerly (1969) we have been able to demonstrate that during a lengthy inhibition of the DNA synthesis with 5-fluoro-uracil (FU), cells assemble just before, at the outset of, and within the S-phase. By taking off the inhibition, these cells start off together for the rest of the life cycle and pass the S, G2 and M phase like a wave. By the experimental condition given, the time required for passing the S phase was rather constant for all tissues. It generally took about 8 h. The sensitivity of cells to radiation depends on the current phase of their life cycle. Normally they are highly radiosensitive during the transition from G1 to S phase and within the G2 phase. Therefore we tried to improve the effectiveness of radiotherapy by radiating the synchronized cell population in the G2 phase. In clinical treatment we give an infusion with 1 g FU in 1000 ml 5.4% Glucose for 12 h. 8--9 h after the end of the infusion radiation will be applied (Betatron, individual doses: 500 rad). This treatment will be repeated until a total dose of 5000--6000 rad. Until now nearly 300 cases of patients treated in this way have been published. The 5 year-results show only in about 60% of the patients a fast reduction of the tumor. The long term results are unsatisfactory. Beside many other points the most important reason for these clinical results might be the individual length of the S phase of the tumors which prevents that radiation can be given exactly in G2 phase in each case. With mitotic-index determination, with cytophotometric investigations and the double labelling technique (3H- and 14C-Thymidine) we therefore tried to find an answer to the following questions: 1. How long is the DNA synthesis time in the individual case of human ENT tumors? 2. Does the application of FU influence the length of the S phase? 3. Will the synchronization-degree become higher by using other methods of cell cycle inhibition? With the above mentioned experimental methods we found that the length of the S phase in human tumor spreads from about 8--16 h in the individual case. The application of FU has no influence on DNA synthesis time. By using FU the degree of synchronization is about 2.5 in according to former experimental work and that of other authors. These results will be discussed in detail as well as the conclusion we draw from our experiments: to give radiation not in G2 but in G1/S of the cell cycle. Long-term observation of the patients and further animal experiments shall demonstrate whether this technique of synchronization therapy will improve the clinical results.
以前(1969年)我们已经能够证明,在用5-氟尿嘧啶(FU)长时间抑制DNA合成期间,细胞恰好在S期之前、开始时以及S期内聚集。去除抑制后,这些细胞一起开始剩余的生命周期,并像波浪一样通过S期、G2期和M期。根据给定的实验条件,所有组织通过S期所需的时间相当恒定。通常需要大约8小时。细胞对辐射的敏感性取决于其生命周期的当前阶段。正常情况下,它们在从G1期向S期过渡以及在G2期内对辐射高度敏感。因此,我们试图通过对处于G2期的同步化细胞群体进行辐射来提高放射治疗的效果。在临床治疗中,我们在1000毫升5.4%葡萄糖中输注1克FU,持续12小时。输注结束后8 - 9小时进行辐射(电子感应加速器,单次剂量:500拉德)。这种治疗将重复进行,直到总剂量达到5000 - 6000拉德。到目前为止,已经发表了近300例以这种方式治疗的患者病例。5年的结果显示,只有约60%的患者肿瘤快速缩小。长期结果并不理想。除了许多其他因素外,这些临床结果最重要的原因可能是肿瘤S期的个体长度,这使得在每种情况下都无法精确地在G2期进行辐射。因此,我们通过有丝分裂指数测定、细胞光度学研究和双标记技术(3H-和14C-胸腺嘧啶)试图找到以下问题的答案:1. 人类耳鼻喉肿瘤个体病例中的DNA合成时间有多长?2. FU的应用是否会影响S期的长度?3. 使用其他细胞周期抑制方法是否会使同步化程度更高?通过上述实验方法,我们发现人类肿瘤中S期的长度在个体病例中约为8 - 16小时。FU的应用对DNA合成时间没有影响。根据以前的实验工作和其他作者的研究,使用FU时同步化程度约为2.5。这些结果将进行详细讨论,以及我们从实验中得出的结论:在细胞周期的G1/S期而不是G2期进行辐射。对患者的长期观察和进一步的动物实验将证明这种同步化治疗技术是否会改善临床结果。